Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Probiotics01:22

Probiotics

68
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
68
Microbes in the Production of Fermented Foods01:27

Microbes in the Production of Fermented Foods

154
Lactic acid bacteria (LAB) and molds are instrumental in fermenting plant-based foods to enhance preservation and ensure year-round availability. These microbial processes convert plant carbohydrates into organic acids and other metabolites that inhibit spoilage organisms and contribute to the sensory qualities of the final product.In sauerkraut production, cabbage goes through a microbial succession that starts with cocci such as Leuconostoc mesenteroides. These microbes begin fermentation by...
154
Microbes in Food Production01:29

Microbes in Food Production

68
Microbial fermentation is central to food biotechnology, enhancing flavor, texture, preservation, and stability. Fermentative microorganisms metabolize carbohydrates into organic acids, alcohols, and other metabolites that inhibit spoilage organisms and improve digestibility while contributing distinctive sensory qualities.In baking, amylases naturally present in flour hydrolyze starch into monosaccharides such as glucose, which Saccharomyces cerevisiae ferments anaerobically. Through...
68
Development of Human Microbiota01:30

Development of Human Microbiota

17
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
17
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

15
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
15
Oral Drug Delivery Systems: Delayed-Release Systems01:11

Oral Drug Delivery Systems: Delayed-Release Systems

134
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
134

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[UTERINE SCAR DEFECT IN WOMEN AFTER CESAREAN SECTION - ULTRASOUND AND HYSTEROSCOPIC DIAGNOSI.]

Akusherstvo i ginekologiiaยท2018
Same author

[Chemotherapy for Malignancy During Pregnancy - Literature Review.]

Akusherstvo i ginekologiiaยท2018
Same author

Defence factors of vaginal lactobacilli.

Critical reviews in microbiologyยท2017
Same author

[COMPARISON OF LAPAROSCOPIC ASSISTED VAGINAL HYSTERECTOMY AND VAGINAL HYSTERECTOMY FOR BENIGN DISEASES AND LESIONS OF THE FEMALE GENITAL SYSTEM].

Akusherstvo i ginekologiiaยท2016
Same author

[Labial fusion in postmenopausal women--a clinical case].

Akusherstvo i ginekologiiaยท2016
Same author

[POLYHEXAMETHYLENE BIGUANID HYDROCHLORIDE (BIGUANELLE) THERAPY OF BACTERIAL VAGINOSIS].

Akusherstvo i ginekologiiaยท2016
Same journal

[POST-PARTUM SEPTIC SACROILIITIS- CASE REPORT AND REVIEW.]

Akusherstvo i ginekologiiaยท2018
Same journal

[TRANSVAGINAL LAPAROSCOPY FOR PELVIC ENDOMETRIOSIS.]

Akusherstvo i ginekologiiaยท2018
Same journal

[NEW TECHNIQUE FOR UTERINE ARTERY IDENTIFICATION.]

Akusherstvo i ginekologiiaยท2018
Same journal

[ULTRASOUND OF THE PLACENTA. NORMAL FINDINGS AND PLACENTAL ABNORMALITIES: A REVIEW.]

Akusherstvo i ginekologiiaยท2018
Same journal

[THE ROLE OF COLPOSCOPY AS A METHOD OF METHODOLOGY FOR EARLY AND RAPID ETIOLOGIC DIAGNOSIS IN THE STUDY OF ENDOCERVICITIS CHLAMYDIALIS.]

Akusherstvo i ginekologiiaยท2018
Same journal

[LAPAROSCOPIC MYOMECTOMY AFTER ULIPRISTAL ACFTATF TRFATMFMT.]

Akusherstvo i ginekologiiaยท2018
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

25.5K

[SLOW RELEASED LOCAL PROBIOTICS].

S Kovachev, A Ganovska, M Stoyanova

    Akusherstvo I Ginekologiia
    |January 29, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Probiotics, live microorganisms conferring health benefits, are increasingly used for vaginal infections. Slow-release probiotics show promise, though further research is needed.

    More Related Videos

    Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
    05:45

    Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

    Published on: April 7, 2023

    4.5K
    Probiotic Studies in Neonatal Mice Using Gavage
    10:36

    Probiotic Studies in Neonatal Mice Using Gavage

    Published on: January 27, 2019

    21.2K

    Related Experiment Videos

    Last Updated: Mar 26, 2026

    Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
    08:38

    Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

    Published on: September 10, 2016

    25.5K
    Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
    05:45

    Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

    Published on: April 7, 2023

    4.5K
    Probiotic Studies in Neonatal Mice Using Gavage
    10:36

    Probiotic Studies in Neonatal Mice Using Gavage

    Published on: January 27, 2019

    21.2K

    Area of Science:

    • Microbiology
    • Gastroenterology
    • Women's Health

    Context:

    • Probiotics are live microorganisms beneficial to the host.
    • Local probiotics are established in medical practice for vaginal disbacteriosis and infections.
    • Studies confirm their effectiveness in managing common vaginal pathogens.

    Purpose:

    • To review the effectiveness of probiotics in treating vaginal infections.
    • To highlight the potential of slow-release probiotics as a newer generation product.

    Summary:

    • Probiotics, live beneficial microorganisms, are integral to treating vaginal disbacteriosis and infections.
    • While traditional probiotics are well-studied, slow-release formulations represent a novel approach.
    • Limited clinical trials exist for slow-release probiotics due to production complexities, but expectations are high.

    Impact:

    • Probiotics offer a viable therapeutic option for vaginal health.
    • Slow-release probiotics may provide enhanced efficacy and patient compliance.
    • Further clinical investigation is warranted to fully establish the benefits of slow-release probiotics.